Beijing Tiantan Biological Products Corp Ltd Market Cap ($3.62 Billion)
Market Cap & Net Worth: Beijing Tiantan Biological Products Corp Ltd (600161)
Beijing Tiantan Biological Products Corp Ltd market cap. Beijing Tiantan Biological Products Corp Ltd (SHG:600161) has a market capitalization of $3.62 Billion (CN¥24.74 Billion) as of November 10, 2026. Listed on the SHG stock exchange, this China-based company holds position #4257 globally and #611 in its home market, demonstrating a 1.62% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Tiantan Biological Products Corp Ltd's stock price CN¥12.51 by its total outstanding shares 1977371446 (1.98 Billion). Also see cash flow conversion of Beijing Tiantan Biological Products Corp for how efficiently the company converts equity into cash flow.
Beijing Tiantan Biological Products Corp Ltd Market Cap History (2015–2026)
Beijing Tiantan Biological Products Corp Ltd market cap history from 2015 to 2026. Data shows growth from $3.35 Billion to $3.62 Billion (2.62% CAGR). Check 600161 live share price for real-time trading data and today's change.
Index Memberships
Beijing Tiantan Biological Products Corp Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Shanghai Shenzhen CSI 300
CSI300
|
$4.01 Trillion | 0.09% | #150 of 285 |
Weight: Beijing Tiantan Biological Products Corp Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Beijing Tiantan Biological Products Corp Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Tiantan Biological Products Corp Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Beijing Tiantan Biological Products Corp (600161) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.98x
Beijing Tiantan Biological Products Corp Ltd's market cap is 0.98 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.83x
Beijing Tiantan Biological Products Corp Ltd's market cap is 3.83 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.35 Billion | $1.62 Billion | $9.98 Million | 2.07x | 336.07x |
| 2016 | $3.78 Billion | $2.14 Billion | $256.89 Million | 1.77x | 14.72x |
| 2017 | $3.62 Billion | $2.48 Billion | $1.17 Billion | 1.46x | 3.09x |
| 2018 | $3.51 Billion | $2.93 Billion | $509.48 Million | 1.20x | 6.89x |
| 2019 | $5.55 Billion | $3.28 Billion | $611.09 Million | 1.69x | 9.08x |
| 2020 | $9.96 Billion | $3.45 Billion | $639.01 Million | 2.89x | 15.58x |
| 2021 | $6.94 Billion | $4.11 Billion | $760.01 Million | 1.69x | 9.13x |
| 2022 | $6.85 Billion | $4.26 Billion | $880.92 Million | 1.61x | 7.78x |
| 2023 | $8.95 Billion | $5.18 Billion | $1.11 Billion | 1.73x | 8.07x |
| 2024 | $5.93 Billion | $6.03 Billion | $1.55 Billion | 0.98x | 3.83x |
Competitor Companies of 600161 by Market Capitalization
Companies near Beijing Tiantan Biological Products Corp Ltd in the global market cap rankings as of November 10, 2026. Also see balance sheet size of Beijing Tiantan Biological Products Corp for a full breakdown of the balance sheet.
Key companies related to Beijing Tiantan Biological Products Corp Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #179 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #410 globally with a market cap of $68.92 Billion USD ( AU$97.40 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #502 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #179 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $550.87 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $919.96 |
| #410 | CSL Ltd | AU:CSL | $68.92 Billion | AU$200.77 |
| #502 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $269.00 |
Market Capitalization of Beijing Tiantan Biological Products Corp Ltd (2015–2026)
Market capitalization of Beijing Tiantan Biological Products Corp Ltd from 2015 to today. Between 2015 and today, Beijing Tiantan Biological Products Corp Ltd's market cap moved from $3.35 Billion to $ 3.62 Billion, with a yearly change of 2.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.62 Billion | -23.44% |
| 2025 | CN¥4.73 Billion | -20.29% |
| 2024 | CN¥5.93 Billion | -33.74% |
| 2023 | CN¥8.95 Billion | +30.64% |
| 2022 | CN¥6.85 Billion | -1.19% |
| 2021 | CN¥6.94 Billion | -30.35% |
| 2020 | CN¥9.96 Billion | +79.37% |
| 2019 | CN¥5.55 Billion | +58.13% |
| 2018 | CN¥3.51 Billion | -3.07% |
| 2017 | CN¥3.62 Billion | -4.23% |
| 2016 | CN¥3.78 Billion | +12.80% |
| 2015 | CN¥3.35 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 10th, 2026 the market cap of Beijing Tiantan Biological Products Corp Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.62 Billion USD |
| MoneyControl | $3.62 Billion USD |
| MarketWatch | $3.62 Billion USD |
| marketcap.company | $3.62 Billion USD |
| Reuters | $3.62 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Tiantan Biological Products Corp Ltd
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamin… Read more